FANNIN PARTNERS LLC
- HOUSTON, TX 77027-5175
- fannininnovation.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
FANNIN PARTNERS LLC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About FANNIN PARTNERS LLC
- Headquarters
- HOUSTON, TX 77027-5175
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIDAHAYJEBV8K1
- CAGE7A2S4
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 15 awards
- Total awarded
- $10,167,978
- By phase
- SBIR Phase I: 11
- SBIR Phase II: 4
- By agency
- Department of Health and Human Services: 15
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2025: 1
- 2024: 1
- 2023: 1
- 2022: 2
- 2021: 1
- 2020: 1
- 2019: 2
- 2018: 2
- 2017: 4
Awards (most recent first)
Developing Scg3 Raptamers as a novel targeted therapy for wet AMD
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2025 · $300,016
Sep 1, 2025 – Aug 31, 2026
Solicitation PA24-245 (2024) · Topic NEI
Investigation of a Novel PDE4B Inhibitor for Stimulant Use Disorder
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $320,000
May 1, 2024 – Apr 30, 2025
Solicitation DA23-021 (2023) · Topic NIDA
Bedside right-heart catheterization for early diagnosis and more effective management of patients with heart failure and primary pulmonary hypertension
SBIR Phase I · Department of Health and Human Services (Food and Drug Administration) · 2023 · $199,972
Sep 29, 2023 – Sep 28, 2024
Solicitation PA22-176 (2022) · Topic FDA
Expediting the Biomarker Discovery Process Through a Novel Bead-Based Aptamer Capture Platform
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2022 · $299,921
Aug 15, 2022 – Aug 14, 2023
Solicitation PA21-259 (2021) · Topic 400
Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2022 · $2,084,309
Apr 1, 2022 – Aug 31, 2026
Solicitation PA21-260 (2021) · Topic NCI
Aptamer therapeutic for safe and low-cost treatment of snake bite envenomation
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2021 · $1,972,317
Jul 1, 2021 – Jun 30, 2023
- Direct to Phase II
Solicitation PA19-272 (2019) · Topic 200
Novel inhibitor of PDE4 for the treatment of opioid use disorder
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $349,867
Sep 30, 2020 – Aug 31, 2021
Solicitation PA19-272 (2019) · Topic NIDA
Artificial Urethral Sphincter for Control of Urinary Incontinence in Pediatric Patients
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $224,771
Sep 13, 2019 – Sep 12, 2020
Solicitation PA18-574 (2018) · Topic 400
Uterine Wall-Membrane Anchor Device for the Prevention of Preterm Premature Rupture of the Membranes Following Fetoscopic Surgery
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2019 · $2,119,882
Aug 1, 2019 – Jul 31, 2022
Solicitation PA20-272 (2019) · Topic NICHD
Innovative Delivery of siRNA across the Blood Brain Barrier
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $224,989
Sep 30, 2018 – Aug 31, 2019
Solicitation PA18-574 (2018) · Topic NIA
Preclinical evaluation of a novel small molecule STAT inhibitor
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2018 · $999,993
Aug 20, 2018 – Jul 31, 2019
Solicitation PA18-590 (2017) · Topic NIAID
Uterine Wall Membrane Anchor Device for the Prevention of Preterm Premature Rupture of the Membranes Following Fetoscopic Surgery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $224,642
Sep 21, 2017 – Aug 31, 2019
Solicitation PA16-302 (2016) · Topic NICHD
Ureteral Stent Electromagnetic Removal USER Device for Pediatric Patients
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $224,692
Sep 1, 2017 – Aug 31, 2019
Solicitation PA16-302 (2016) · Topic 400
Novel Small Molecule Targeting STAT Proteins for the Management of Atopic Dermatitis
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $243,014
Aug 16, 2017 – Jul 31, 2019
Solicitation PA16-302 (2016) · Topic NIAID
Reconstituted High Density Lipoprotein Particles as siRNA Carriers
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $379,593
Jul 1, 2017 – Jun 30, 2019
Solicitation PA14-307 (2014) · Topic 100
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Primary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with FANNIN PARTNERS LLC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.